Axon Neurosciences Funding: $340M Raised, Series C (2025)
Axon Neurosciences is based in Bratislava, Slovakia. It has raised $340M in total funding. Latest round: Series C.
Axon Neurosciences funding overview
Axon Neurosciences is based in Bratislava, Slovakia. Axon Neurosciences has raised $340M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in November 2025. The round record for Axon Neurosciences runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, ARCH Venture Partners, Frazier Life Sciences, Revelation Partners, Medical Excellence Capital, S32 and 7 others. 13 distinct backers are named across the disclosed rounds.
Axon Neurosciences at a glance
Total raised
$340M
Latest round
Series C
Latest round date
November 2025
Headquarters
Bratislava, Slovakia
Notable investors
OrbiMed, ARCH Venture Partners, Frazier Life Sciences, Revelation Partners, Medical Excellence Capital, S32, Axon Ventures, LYFE Capital
Frequently asked about Axon Neurosciences funding
How much has Axon Neurosciences raised?
Axon Neurosciences has raised $340M in total disclosed funding across the rounds on record.
Who has invested in Axon Neurosciences?
OrbiMed, ARCH Venture Partners, Frazier Life Sciences, Revelation Partners, Medical Excellence Capital, S32 are named among the investors backing Axon Neurosciences.
What was the latest Axon Neurosciences funding round?
The most recent disclosed round is a Series C, announced in November 2025.
Where is Axon Neurosciences based?
Axon Neurosciences is based in Bratislava, Slovakia.
When did Axon Neurosciences last raise?
The last disclosed Axon Neurosciences round closed in November 2025 at Series C.
We update the Axon Neurosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Bratislava and their backers are listed below.
